Gut microbiome effects on cardiometabolic disease through metabolism-modifying metabolites (Gut-MMM)
Forskningsprojekt, 2016
– 2022
Evidence indicates that the bacterial flora in the human gastrointestinal tract substantially influences metabolism and development of cardiometabolic diseases. Nevertheless, the extent to which these factors are linked and whether pharmaceuticals can be developed on this basis are currently unclear. The underlying hypothesis of the project is that microbially synthesized molecules do not simply play a role as the body’s energy metabolizers and building blocks; they also play an important role as signal molecules that interact with receptors in endocrine organs.
Deltagare
Jens B Nielsen (kontakt)
Chalmers, Life sciences, Systembiologi
Samarbetspartners
Köpenhamns universitet
Köbenhavn, Denmark
Universiteit Van Amsterdam
Amsterdam, Netherlands
Finansiering
Novo Nordisk Fonden
Projekt-id: NNF15OC0016798
Finansierar Chalmers deltagande under 2016–2022
Relaterade styrkeområden och infrastruktur
Hållbar utveckling
Drivkrafter
Livsvetenskaper och teknik (2010-2018)
Styrkeområden